key: cord-0709579-mi3650n4
authors: Ny, Pamela; Kelsom, Corey; Chron, Amanda; Lou, Mimi; Nieberg, Paul; Shriner, Kimberly; Huse, Holly; Wong‐Beringer, Annie
title: Factors associated with prompt recovery among hospitalised patients with coronavirus disease 2019
date: 2021-09-20
journal: Int J Clin Pract
DOI: 10.1111/ijcp.14818
sha: a16eead4bee37dac5c9d3088e02f8655b4fe9eae
doc_id: 709579
cord_uid: mi3650n4

BACKGROUND: Patients who survived hospitalisation for COVID‐19 experienced varying durations of illness but the factors associated with prompt recovery are unknown. This study identifies factors differentiating hospitalised patients who recovered promptly versus survived a prolonged course of illness because of COVID‐19. METHODS: This was a retrospective study from March‐August 2020 of hospitalised adults with COVID‐19 which were grouped based on time to recovery: short (≤3 days), intermediate (4‐10 days) and prolonged (>10 days). Recovery was defined as resolution of fever, tachypnea, hypotension, extubation and return of mental status at baseline. Multivariate analysis was used to evaluate factors associated with prompt recovery. RESULTS: Among 508 patients hospitalised for COVID‐19, 401 (79%) survived. Of those, prompt recovery (within 3 days) was achieved in 43% (174/401), whereas 23% (92/401) recovered after a prolonged period of >10 days. Overall, median age was 64 years with 73% admitted from home and 25% from a skilled nursing facility. Predictors for prompt recovery upon admission included female sex (OR, 1.8; 95% CI, 1.1‐2.7; P = .01), no fever (OR, 1.6; 95% CI, 1.1‐2.6; P = .03), longer time from symptom onset to hospitalisation (OR, 1.1; 95% CI, 1.0‐1.1; P = .001), no supplemental oxygen (OR, 1.9; 95% CI, 1.2‐3.0; P = .004), no direct ICU admission (OR, 41.7; 95% CI, 2.4‐740.4; P = .01) and absence of bacterial co‐infections (OR, 2.5; 95% CI, 1.5‐4.0, P = .0003). CONCLUSIONS: Our study provides relevant data that could help clinicians triage competing resources in health systems that are challenged by the ebb and flow of COVID‐19 cases by identifying clinical features of COVID‐19 patients who may require less intensive management including avoidance of unnecessary antibacterial therapy.

Results: Among 508 patients hospitalised for COVID-19, 401 (79%) survived. Of those, prompt recovery (within 3 days) was achieved in 43% (174/401), whereas 23% (92/401) recovered after a prolonged period of >10 days. Overall, median age was 64 years with 73% admitted from home and 25% from a skilled nursing facility.

Predictors for prompt recovery upon admission included female sex (OR, 1.8; 95% CI, 1.1-2.7; P = .01), no fever (OR, 1.6; 95% CI, 1.1-2.6; P = .03), longer time from symptom onset to hospitalisation (OR, 1.1; 95% CI, 1.0-1.1; P = .001), no supplemental oxygen (OR, 1.9; 95% CI, 1.2-3.0; P = .004), no direct ICU admission (OR, 41.7; 95% CI, 2.4-740.4; P = .01) and absence of bacterial co-infections (OR, 2.5; 95% CI, 1.5-4.0, P = .0003).

Our study provides relevant data that could help clinicians triage competing resources in health systems that are challenged by the ebb and flow of COVID-19 cases by identifying clinical features of COVID-19 patients who may require less intensive management including avoidance of unnecessary antibacterial therapy.

nationwide and globally, our study aims to identify features associated with prompt recovery to help clinicians triage management of patients hospitalised for COVID-19. Medical charts were reviewed to obtain demographic, laboratory and clinical information, and details of antiviral and antibacterial therapy. All data were recorded on a structured data collection form and managed using REDCap electronic data capture tools hosted at the University of Southern California. 4 Sepsis-3 criteria were used to define sepsis and septic shock. 5 Outcome measures included development of acute kidney injury (AKI) and acute respiratory distress syndrome (ARDS) and hospital length of stay (LOS).

Patients were grouped based on short (≤3 days), intermediate (4- 

Survival rate was 79% (401/508) among patients hospitalised for COVID-19 during the study period. Overall, median age of COVID-19 survivors was 64 years; majority (73%) were admitted from home with 25% from a skilled nursing facility (SNF). The overall median TTS was 4 days (IQR: 2-10) for survivors, with 43% (n = 174) within 3 days, 34% (n = 135) between 4-10 days and 23% (n = 92) after a prolonged period exceeding 10 days. More females achieved prompt versus prolonged time to recovery (51% vs 37%; less patients with a short TTS developed AKI (10% vs 17% vs 34%, P < .0001) and none developed ARDS (vs 1% vs 17%, P < .0001) (Table 1) . Ultimately, those who recovered fastest experienced a shorter hospital stay (median 5 vs 9 vs 22 days, P < .0001; Table 1 ).

By multivariable logistic regression analysis, independent predictors for prompt recovery from COVID-19 were female sex, absence of fever, longer time from symptom onset to hospitalisation, no direct ICU admission, not requiring supplemental oxygen upon presentation and absence of presumed or documented co/secondary bacterial infections (Table 2 ).

Patients who survived hospitalisation with COVID-19 experienced varying time to achieve clinical stability before hospital discharge. shown a correlation between men with COVID-19 and worse outcomes including death, our data is the first to show an association between female sex and shortened recovery time. 6, 7 Our data is also the first to show that an extended time from symptom onset to hospital admission is a predictor for prompt recovery.

We found that significantly less patients with prompt recovery had bacterial co-infections especially concurrent pneumonia com- 

Health system resources may be triaged accordingly based on clinical features associated with prompt recovery in patients hospitalised for COVID-19. Concurrent antibacterial therapy needs to be judiciously prescribed to minimise the selection of antimicrobial resistance and untoward adverse effects (eg C difficile diarrhea). 

The authors declared no conflict of interest.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

How to cite this article: Ny P, Kelsom C, Chron A, et al. TA B L E 2 Predictors of prompt recovery by multivariable logistic regression a

The novel coronavirus originating in Wuhan, China: challenges for global health governance

Severe acute respiratory syndrome-related coronavirus: the species and its viruses-a statement of the Coronavirus Study Group

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering

Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support

The third international consensus definitions of sepsis and septic shock (Sepsis-3)

Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health

Impact of sex and gender on COVID-19 outcomes in Europe